PD-1Ab21 stimulated the differentiation of activated T cells back to memory stem T cells (TSCM) and had potent antitumor effects in various established tumor models by promoting tumor-specific memory CD8+ T cell responses. The gene discussed is CD8A; the disease is neoplasm.